BRIEF published on 06/08/2026 at 07:05, 2 months 24 days ago ADOCIA presents promising results for BioChaperone® Lispro Positive Results Phase 3 Type 2 Diabetes BioChaperone Lispro Blood Glucose Control
BRIEF published on 06/08/2026 at 07:05, 2 months 24 days ago Adocia's BioChaperone® Lispro: Promising Phase 3 Results Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro Glycemic Control
PRESS RELEASE published on 06/08/2026 at 07:00, 2 months 24 days ago Inside Information / Other news releases Adocia announces positive Phase 3 results of BioChaperone® Lispro for type 2 diabetes, presenting superior glycemic control benefits over Humalog® Type 2 Diabetes Phase 3 Results ADOCIA BioChaperone® Lispro ADA 86th Scientific Session
BRIEF published on 04/21/2026 at 20:35, 4 months 10 days ago Adocia Reports 2025 Financial Results and Strategic Developments Corporate Governance Financial Results 2025 Biopharmaceutical Advancements BioChaperone® Technology Partnerships And Patents
PRESS RELEASE published on 04/21/2026 at 20:30, 4 months 10 days ago Inside Information / News release on accounts, results ADOCIA announces full year 2025 financial results, highlights positive Phase 3 results for diabetes treatment, and secures cash runway until Q2 2027. Company advancements in key technology platforms showcased Financial Results Diabetes Treatment Phase 3 Results ADOCIA Technology Platforms
BRIEF published on 04/21/2026 at 19:35, 4 months 10 days ago ADOCIA concludes a financial agreement with Vester Finance Treasury Funding Biopharmaceutical ADOCIA Vester Finance
BRIEF published on 04/21/2026 at 19:35, 4 months 10 days ago ADOCIA Secures €6 Million Shareholder Loan from Vester Finance Shareholder Loan Cash Runway ADOCIA BioChaperone® Vester Finance
PRESS RELEASE published on 04/21/2026 at 19:30, 4 months 10 days ago Inside Information / Other news releases Adocia secures €6.0 million shareholder loan from Vester Finance, extending cash runway until Q2 2027. Funds for BioChaperone and AdoXLong development Shareholder Loan ADOCIA Vester Finance Cash Runway Extension BioChaperone
BRIEF published on 12/08/2025 at 19:35, 8 months 24 days ago ADOCIA Announces Share and Voting Rights Update Voting Rights Shares Financial Disclosure Diabetes Treatment ADOCIA
PRESS RELEASE published on 12/08/2025 at 19:30, 8 months 24 days ago Inside Information / Other news releases Adocia SA releases total number of shares and voting rights as of December 8th, 2025. Company focuses on innovative therapeutic solutions for diabetes and obesity Voting Rights Shares Diabetes Obesity ADOCIA
Published on 09/01/2026 at 23:05, 8 hours 31 minutes ago Aton Announces US$30M Credit Facility with OU Moonrider
Published on 09/01/2026 at 22:30, 9 hours 6 minutes ago Algo Grande Copper Closes Oversubscribed Private Placement for $4.786 Million
Published on 09/01/2026 at 22:15, 9 hours 21 minutes ago NuRAN Wireless Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
Published on 09/01/2026 at 16:10, 15 hours 26 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/02/2026 at 07:00, 36 minutes ago VIB Vermögen AG: Further tenancy agreements concluded for 3,300 m2 of office and service space at the HCC Dortmund
Published on 09/02/2026 at 07:00, 36 minutes ago BioVersys granted Fast-Track Designation from US FDA for BV100
Published on 09/02/2026 at 07:00, 36 minutes ago Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
Published on 09/02/2026 at 07:00, 36 minutes ago Infracore discloses key terms of its binding offer for the real estate of Wetzikon Hospital
Published on 09/01/2026 at 19:00, 12 hours 36 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 18:18, 13 hours 18 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - August 2026
Published on 09/01/2026 at 17:44, 13 hours 52 minutes ago Reporting on share buyback transactions carried out between August 18 and August 28, 2026
Published on 09/01/2026 at 17:39, 13 hours 57 minutes ago Disclosure of transactions in own shares of 31 August, 2026
Published on 08/31/2026 at 17:45, 1 day 13 hours ago Disclosure of transactions in own shares from August 24 to August 28, 2026
